- Types of Equipment That Surgeons Need for Their Practice
- MGI Tech partners with Eva Holding Group to enhance the accuracy of disease monitoring
- FDA Grants Fast Track Designation for AJ201, a First-in-Class Therapy for Kenndy’s Disease
- Sanofi Deepens Partnership with Medidata | To Expedite the Development of New Therapies with an Improved Patient Journey
- HOMELINK® Appoints Allan Schroeder as Vice President of Managed Care
- Invenra Inc. and Xcellon Biologics Announce Collaboration to Advance Bispecific and Trispecific Antibody-Drug Conjugate (ADC) Development
- Materna Medical Presents a Sub-Analysis Comparing Outcomes on a Spectrum of Menopausal Women, Showing Significant Improvements at Three Months
Medical Device News Magazine delivers the latest updates from the medical device and biotechnology sectors.
Stay Ahead in Medical Technology
At Medical Device News Magazine, we take pride in delivering high-quality, in-depth news. Our content goes beyond the surface, providing a comprehensive look at the trends, innovations, and breakthroughs that are shaping the future of medical technology.
In addition, we aim to offer a unique perspective on the rapidly evolving healthcare landscape. By following our news, you gain exclusive insights into industry developments, emerging technologies, and regulatory updates that impact medical devices worldwide. At the same time, you become part of a vibrant community of professionals, innovators, and thought leaders who are dedicated to advancing healthcare through cutting-edge solutions.
Furthermore, we encourage you to explore our diverse range of content, from the latest product announcements to in-depth analyses of industry trends. If our vision aligns with your objectives, we also offer opportunities for advertising and collaboration, allowing you to reach a highly engaged audience of medical technology professionals.
Stay informed, stay connected, and join us as we navigate the future of healthcare together.
Medical Device Industry News: Latest Developments, Breakthroughs, and Future Outlook
Movora Becomes Exclusive Distributor of Aesculap Surgical Power Systems in North America
Guy Spörri, CEO of Movora said, “This agreement represents a significant step forward in our mission to support veterinary professionals with world-class surgical technologies.”
HNL Lab Medicine Opens New Location at Tower Place in Bethlehem
Leanne Anderson, Marketing Director at HNL Lab Medicine: “It’s important to us that children feel safe and parents feel supported. This new location is one more way we’re helping families get the care they need, close to home.”
Medtronic 1st in the U.S. to Offer 400 cm 0.018” Peripheral Guidewire for Transradial Access
This agreement includes the first 400 cm, 0.018″ peripheral guidewire available in the U.S, expanding the Medtronic portfolio for transradial access for the treatment of peripheral arterial disease (PAD).
Recor Medical Supports Proposed CMS National Coverage Determination of Renal Denervation for the Treatment of Hypertension
“We are encouraged by CMS’s proposed decision to provide Medicare coverage for uRDN in patients with uncontrolled hypertension—a population that continues to face significant unmet need,” said Lara Barghout, CEO of Recor Medical.
Clinical Trials
Precision Study Underway – 100 Prostate Cancer Patients Treated in Just 3 Radiation Sessions
“The goal of the Precision Study is to ensure that treatment with three radiation doses does not lead to greater side effects than those observed in the Pace-B study. I am confident that we can demonstrate effective cancer treatment with less side effects,” says Professor McLaren.
City of Hope Opens Trial to Test Bone Medication for Early Type 1 Diabetes Treatment
“This is an exciting new application of a known medication that, in addition to potentially protecting and/or expanding the beta cells that remain in early type 1 diabetes patients, might also be able to help other patients with diabetes to increase beta cell number and/or function,” said Fouad R. Kandeel, M.D., Ph.D., the Arthur D. Riggs Distinguished Chair in Diabetes & Metabolism Research at City of Hope and the trial’s co-principal investigator. “We are actively working to enroll qualified patients and look forward to seeing where this trial leads us.”
REGENXBIO Reports Positive Biomarker Data from the AFFINITY DUCHENNE ®Trial of RGX-202 Gene Therapy
“RGX-202 is the only next generation gene therapy for Duchenne in a pivotal phase trial. The new data from the age 1-3 cohort builds on the favorable safety and efficacy profile seen in ages 4 and older and reinforces the potential of RGX-202 to serve a wide age range of patients,” said Steve Pakola, M.D., Chief Medical Officer of REGENXBIO.
Biotechnology News
VERAXA Biotech and Voyager Acquisition Corp. Announce Business Combination Agreement to Create Nasdaq-Listed Biopharmaceutical Company Advancing a Pipeline of Next-Generation Cancer Therapies
VERAXA Biotech’s majority shareholders are Xlife Sciences AG (SIX: XLS), a Swiss-based publicly listed life science incubator fund, the European Molecular Biology Laboratory (“EMBL”), and its technology transfer arm EMBLEM.
Medicus Pharma Provides Update on SKNJCT-003 Phase 2 Clinical Study for the Treatment of Nodular Basal Cell Carcinoma
The Institutional Review Board Has Approved the Increase in Number of Patients from Sixty (60) to Ninety (90). The Company to Expand the Study into Additional Trial Sites in Europe.
ARUP Laboratories Launches pTau 217 Blood Test To Detect Alzheimer’s Disease Pathology
As this biomarker can be detected in blood, this test is a minimally invasive and broadly accessible diagnostic tool that may facilitate earlier detection of AD.
Our Experts – Byline Articles
Read Their Views & Share With a Colleague or Two!
Scaling with Demand: Requirements for Success in Medical Device Manufacturing | By Laura Beckwith, Director of Product Management, Configit
Our expert writes: Historically, medical device companies have provided value by producing equipment for diagnosing and treating patients worldwide. However, contemporary challenges such as heightened pricing pressures, regulatory compliance, supply chain volatility and operational inefficiencies have significantly changed the landscape for these companies.
Optimizing Biopharma Workflows: Integrating AI to Enhance Research and Discovery | By Christian Olsen, Associate VP & Industry Principal for Biologics at Dotmatics
The integration of AI in biopharma workflows is not just a technological advancement, but a paradigm shift that promises to completely revolutionize how we research, understand, and treat diseases. Read what this expert has to say.
Plaque Quantification In Coronary Arteries Is a ‘Game-changer’ | By Campbell Rogers, M.D., F.A.C.C., Executive Vice President & Chief Medical Officer, HeartFlow
Artificial intelligence provides a simpler and faster alternative and could be a potential game-changer for their heart patients. For example, HeartFlow’s AI-enabled Plaque Analysis tool leverages an automated, deep learning-based, non-invasive method for identifying, characterizing, and segmenting plaque throughout the coronary arteries. By offering a more comprehensive view, plaque analysis tools can improve diagnostic accuracy, enhance treatment planning, and help stratify risk.
Executives on the Move
Dan Cummings Is Appointed Chief Commercial Officer of Precision AQ
Dan Cummings will be responsible for Precision AQ’s commercial and go-to-market strategies, with the goal of bringing Precision AQ’s comprehensive suite of capabilities to help biopharmaceutical companies advance life-changing therapies to market.
Boston Scientific Chief Financial Officer Dan Brennan to Retire | Jon Monson, SR VP, Investor Relations to succeed Brennan
Brennan will transition out of the chief financial officer position at the end of June and is expected to remain with Boston Scientific as a senior advisor through early October 2025.
New Executive Appointments Announced Avania
“We recognize the MedTech industry is consistently changing and remain committed to providing flexible solution-driven partnerships that guide our clients from concept to commercialization. Our ability to navigate the changes in the industry is rooted in the strength of our team,” said Jason Monteleone, president and CEO of Avania.
FDA Medical Device Updates
Comprehensive Insights into Medical Device & Biotechnology Company Mergers, Acquisitions & Funding
Nuclera Closes $75 Million USD Financing
The funding will accelerate the commercialization of the Nuclera eProtein Discovery platform, to optimize protein expression and purification workflows within research labs globally
Biocomposites Invests in InfectoTest GmbH | Developers of a Bacterial-specific Point-of-care Test for Periprosthetic Joint infection
Michael Harris, Chief Executive Officer of Biocomposites, said: “Periprosthetic joint infection is a large and growing problem worldwide. Quickly and accurately pinpointing the bacteria that cause each infection is essential if patients are to receive the best care and maximise their chances of full recovery.
Syncona: Resolution Therapeutics Raises £63.5 Million in Series B Financing | Appoints New Chair
Use of proceeds from the Series B financing will support the clinical entry and development of RTX001, with a Phase I/II trial expected to start in Q4 CY2024. Following this financing, Resolution Therapeutics is funded to deliver data from this trial, anticipated in CY2026, a key value inflection point with the potential to drive significant NAV growth for Syncona. Proceeds will also be used to develop the company’s manufacturing platform, expand the pre-clinical pipeline, and further strengthen the management team, following several key recent appointments, including Dr Amir Hefni as CEO, Simon Ramsden as CFO and Dr Clifford A. Brass as CMO.
Celaid Therapeutics Inc. Secures up to $19M Grant from the Japanese Agency for Medical Research and Development
Celaid Therapeutics secures up to approx. $19M non-dilutive grant funding from Japanese government. The grant funding will support the development of Celaid’s hematopoietic stem cell product for pediatric non-malignant diseases.
Market Reports
Advancements In Imaging
Wireless Handheld X-ray Equipment from MinXray Used for Global Health Initiative in Papua New Guinea
MinXray MinXray, a leading manufacturer of imaging systems for medical and veterinary use, recently sent its Impact Wireless X-ray system with a group of researchers
Lunit Expands Presence in Europe | To Deliver AI-powered Cancer Screening Solution to France and Portugal
New supply contract to bring Lunit INSIGHT CXR to TeleDiag in France and Lunit INSIGHT MMG to the Central region branch of the Portuguese League Against Cancer
KA Imaging Reports Record Revenue Plus Strategic Hires
KA Imaging reported a collection of positive metrics to its stakeholders, with revenue four times larger than that of the previous year and a 38% growth in headcount in 2023. The positive trend continues to be observed in Q1 2024.
Hospitals In the News
Medical Device and Biotechnology Executives: Innovative Professionals on the Move and Making Waves in the Industry
Non-Profit News
Healthcare: Understanding the Business Side of the Industry and Its Implications
Vesilut Peptide: Potential Implications in Biological Systems and Scientific Research
Vesilut peptide may hold the key to advancing our understanding of physiological processes and developing innovative approaches to challenges in molecular biology and beyond.
A Comprehensive Tax Planning Guide For Medical Professionals
In this article, doctors can use these strategies to maximize their deductions and receive the most retirement benefits possible.
How to Choose Bags & Cases for Medical Professionals and Students
So, how can one design bags and cases for medical professionals and students? This guide will share the details you need to know.
6 Tips For Mitigating Risks Associated With Running A Med Spa
Running a med spa is a lucrative way to make people look and feel better, but like everything else, it has significant risks.
Healthcare Careers
The Importance of Public Health in Growing Communities
Sadly, it took a pandemic to realize the importance of public health. With the recent outbreak of COVID-19, economies fell, leading to millions of hospitalizations.
Why Pharmacy Is A Great Field For Your Career
There are many different career paths to choose from, but if you’re looking for stability and a good salary, the pharmacy might be the right
What Can You Do With a Biology Degree?
The field of biology covers various areas and studies life in general and is considered one of the most extensive subjects. Everyone can find a
Nurses Corner
Nursing is Officially America’s Dream Job | So why the Staffing Shortages?
In a study to find out America’s most desirable jobs, analysts at Business Name Generator found that nursing is the most in-demand career in the country. They analyzed over 22,000 search terms related to job seeking to identify the most-searched-for professions. Six of the top 20 most popular jobs are in the healthcare industry.
What to Look for When Choosing an Online MSN Program
If you’re a nurse seeking career advancement, a master’s degree in nursing can offer specialized skills and training. Earning a master’s in nursing can lead
Linda D Scott Assumes Presidency of the American Academy of Nursing
Linda D. Scott, PhD, RN, NEA-BC, FNAP, FAAN, started her term as President of the American Academy of Nursing (Academy) at the organization’s annual business
